# StemCyte, Inc – FDA Inspection, Mar 12, 2013

Source: https://www.keypedia.com/records/fda_inspections/stemcyte-inc/9e207d14-46c2-4b4c-88d8-ef7c1db86ae9
Source feed: FDA_Inspections

> FDA inspection 821099 of StemCyte, Inc, March 12, 2013. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 1271. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 821099
- Company Name: StemCyte, Inc
- Inspection Date: 2013-03-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1291150 - 2026-03-24](https://www.keypedia.com/records/fda_inspections/stemcyte-inc/fe5f8458-e932-47ff-a32a-9ff2060b47b0)
- FDA Inspection 1101775 - 2019-07-31
- FDA Inspection 736757 - 2011-07-28
- [FDA Inspection 643295 - 2010-02-11](https://www.keypedia.com/records/fda_inspections/stemcyte-inc/2097e50c-919e-462b-86be-7efda227177e)

Company: https://www.keypedia.com/companies/stemcyte-inc/8d9f9d48-8d24-4ba3-8af0-707de0bb4595

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
